These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7940834)

  • 1. Optimal clinical regimens for living related liver transplantation.
    Malagó M; Rogiers X; Wadström J; Burdelski M; Broelsch CE
    Transplant Proc; 1994 Oct; 26(5):2665-8. PubMed ID: 7940834
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
    Lemmens HP; Langrehr JM; Blumhardt G; Lohmann R; Knoop M; Verschl J; Schattenfroh N; Neuhaus R; Hopf U; Bechstein WO
    Transplant Proc; 1994 Dec; 26(6):3622-3. PubMed ID: 7527983
    [No Abstract]   [Full Text] [Related]  

  • 3. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 4. Short- and long-term cyclosporine dosage in liver transplantation.
    McCaughan GW; Bookallil MJ; Sheil AG
    Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal immunosuppressive clinical regimen in liver transplantation.
    Farges O; Samuel D; Bismuth H
    Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatric liver transplantation: delay in initiation of cyclosporine therapy beyond the immediate postoperative period does not adversely affect outcome.
    Lynch SV; Yamanaka J; Balderson GA; McEniery JA; Delbridge RG; Ong TH; Pillay SP; Strong RW
    Transplant Proc; 1994 Oct; 26(5):2771-4. PubMed ID: 7940873
    [No Abstract]   [Full Text] [Related]  

  • 7. Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression.
    Francis DM; Walker RG; Millar RJ; Becker G
    Transplant Proc; 1992 Oct; 24(5):1887-8. PubMed ID: 1412899
    [No Abstract]   [Full Text] [Related]  

  • 8. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
    McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract]   [Full Text] [Related]  

  • 12. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of immunosuppressive agents after living related donor liver transplantation.
    Tanaka M; Otobe Y; Hashimoto T; Shimizu Y; Suzuki T; Nakamura Y; Itoh K; Satoh M; Ueda N; Manabe T
    Transplant Proc; 1996 Aug; 28(4):2402-3. PubMed ID: 8769268
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical results of quadruple drug immunosuppression in liver transplantation.
    Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S
    Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
    Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract]   [Full Text] [Related]  

  • 17. Sri Lankan experience with three immunosuppressive protocols in living related donor kidney transplantation.
    Sheriffdeen AH; de Abrew K; Jayasekera G; Nanayakkara S; de Mel CP; Jayasinghe S; Fernando H; Rajakanthan K; Weerasinghe A; Kuruppruarchchi L
    Transplant Proc; 1992 Oct; 24(5):1818. PubMed ID: 1412862
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 20. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.